Up to 25 percent of U.S. economic growth since World War II can be traced directly to government investment in non-defense research and development. This data point, a cornerstone of post-war prosperity, serves as the central argument in a new strategic roadmap for American industrial policy. Published this week by the MIT Press, the book “Priority Technologies: Ensuring U.S. Security and Shared Prosperity” argues that the nation’s future hinges on a pivot from purely theoretical innovation to the aggressive rebuilding of domestic manufacturing capacity.
Follow the money, and the structural weakness of the U.S. economy becomes clear: we have successfully exported the "how" of production while retaining the "what" of design. Elisabeth Reynolds, an MIT expert on industrial innovation and editor of the new volume, notes that this decoupling has left the country exposed. The book identifies six sectors—semiconductors, biotechnology, critical minerals, drones, quantum computing, and advanced manufacturing—where the U.S. currently risks losing its competitive edge.
The semiconductor industry provides the most jarring example of this vulnerability. Jesús A. del Alamo, the Donner Professor of Science in MIT’s Department of Electrical Engineering and Computer Science, characterizes chips as “the oxygen of modern society.” The economic cost of this dependency was quantified in 2021, when a global chip shortage accounted for approximately one-third of the inflation experienced by the U.S. economy. According to Reynolds, the recent legislative and private-sector push to bring leading-edge logic chip manufacturing back to domestic soil is not merely a strategic preference; it is a necessary correction to a systemic failure.
In the biotech sector, the challenge is similarly defined by a manufacturing bottleneck. While the U.S. dominates the research phase, it lacks the infrastructure to scale production at the speed of its own innovation. J. Christopher Love, the Laurent Professor of Chemical Engineering at MIT, argues that smaller, more flexible production facilities are the key to leapfrogging international competitors. The stakes are immense: successfully capturing the manufacturing side of this sector would grant the U.S. a foothold in a market projected to reach $4 trillion over the next 15 years.
This industrial strategy relies on the “flow of innovation,” a concept championed by the late MIT president Vannevar Bush in the 1940s. Simon Johnson, the Ronald A. Kurtz (1954) Professor of Entrepreneurship at the MIT Sloan School of Management and a 2024 Nobel laureate, emphasizes that the goal is to turn this research pipeline into high-quality domestic jobs. For investors, the book’s thesis points toward a long-term shift in capital allocation. The era of prioritizing purely software-based, asset-light business models may be reaching its limit as the federal government and private sector pivot toward hardware-heavy, physically substantial industrial growth.
For the individual investor or consumer, the takeaway is clear: watch the capital expenditure trends in supply chain infrastructure. The next reading of domestic manufacturing output metrics will serve as a primary indicator of whether this "priority technology" roadmap is gaining traction or stalling against global competition. As Johnson notes, these sectors are not speculative science fiction; they are current, active requirements for national stability. The focus now shifts to whether the U.S. can effectively translate its research leadership into a durable, profitable industrial base.
